Company Filing History:
Years Active: 2025
Title: Harsovin Kaur - Innovator in Drug Delivery Systems
Introduction
Harsovin Kaur is a notable inventor based in Calgary, Canada. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on silica modified vaterite Janus nanoparticles. His research focuses on enhancing the efficacy of drug delivery methods, which can have a profound impact on medical treatments.
Latest Patents
Harsovin Kaur holds a patent for "Silica modified vaterite Janus drug delivery particles." This patent describes the synthesis of silica modified vaterite Janus nanoparticles, utilizing a scalable aqueous process through a Pickering emulsion. The unique properties of these nanoparticles allow for chemical modifications, making them suitable for various applications, including the incorporation of physiologically acceptable labels.
Career Highlights
Kaur is currently associated with Uti Limited Partnership, where he continues to advance his research in drug delivery technologies. His work is characterized by a commitment to innovation and practical applications in the medical field. With a patent portfolio that includes 1 patent, he is recognized for his contributions to improving drug delivery systems.
Collaborations
Harsovin Kaur collaborates with Giovanniantonio Natale, working together to explore new avenues in drug delivery and nanoparticle technology. Their partnership exemplifies the collaborative spirit of innovation in research and development.
Conclusion
Harsovin Kaur's work in the field of drug delivery systems highlights the importance of innovation in medical technology. His contributions, particularly through his patented work on silica modified vaterite Janus nanoparticles, demonstrate the potential for advancements in treatment methodologies.